Mn Services Vermogensbeheer B.V. Has $23.67 Million Holdings in Colgate-Palmolive Company $CL

Mn Services Vermogensbeheer B.V. increased its holdings in shares of Colgate-Palmolive Company (NYSE:CL) by 2.8% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 299,488 shares of the company’s stock after acquiring an additional 8,069 shares during the period. Mn Services Vermogensbeheer B.V.’s holdings in Colgate-Palmolive were worth $23,666,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of the business. Copia Wealth Management bought a new position in Colgate-Palmolive in the 3rd quarter valued at $29,000. Cloud Capital Management LLC bought a new stake in shares of Colgate-Palmolive during the third quarter worth $30,000. Global Wealth Strategies & Associates grew its holdings in shares of Colgate-Palmolive by 300.0% during the fourth quarter. Global Wealth Strategies & Associates now owns 400 shares of the company’s stock worth $32,000 after purchasing an additional 300 shares during the last quarter. Grove Bank & Trust increased its stake in shares of Colgate-Palmolive by 182.6% in the fourth quarter. Grove Bank & Trust now owns 407 shares of the company’s stock valued at $32,000 after buying an additional 263 shares in the last quarter. Finally, Kelleher Financial Advisors bought a new position in shares of Colgate-Palmolive in the third quarter valued at about $35,000. 80.41% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several research analysts recently issued reports on CL shares. Bank of America upped their price target on shares of Colgate-Palmolive from $90.00 to $100.00 and gave the stock a “buy” rating in a research report on Monday, February 2nd. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Colgate-Palmolive in a research note on Wednesday, January 21st. Barclays upped their target price on shares of Colgate-Palmolive from $83.00 to $88.00 and gave the stock an “equal weight” rating in a research report on Tuesday, February 3rd. Royal Bank Of Canada raised shares of Colgate-Palmolive from a “sector perform” rating to an “outperform” rating and set a $88.00 price target on the stock in a research note on Tuesday, December 9th. Finally, UBS Group boosted their price objective on shares of Colgate-Palmolive from $90.00 to $93.00 and gave the stock a “buy” rating in a research report on Wednesday, January 14th. Eleven analysts have rated the stock with a Buy rating and six have given a Hold rating to the company’s stock. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus price target of $95.19.

Colgate-Palmolive Price Performance

Shares of CL stock opened at $85.31 on Wednesday. The firm has a market cap of $68.44 billion, a price-to-earnings ratio of 32.56, a PEG ratio of 3.84 and a beta of 0.28. Colgate-Palmolive Company has a 12 month low of $74.54 and a 12 month high of $99.33. The company has a quick ratio of 0.54, a current ratio of 0.83 and a debt-to-equity ratio of 18.82. The stock has a 50-day moving average price of $91.13 and a 200 day moving average price of $83.40.

Colgate-Palmolive (NYSE:CL) last released its earnings results on Friday, January 30th. The company reported $0.95 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.91 by $0.04. The company had revenue of $5.23 billion for the quarter, compared to the consensus estimate of $5.13 billion. Colgate-Palmolive had a net margin of 10.45% and a return on equity of 353.72%. The company’s revenue was up 5.8% compared to the same quarter last year. During the same period in the prior year, the company posted $0.91 EPS. Research analysts expect that Colgate-Palmolive Company will post 3.75 EPS for the current year.

Colgate-Palmolive Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, May 15th. Investors of record on Monday, April 20th will be issued a $0.53 dividend. This is an increase from Colgate-Palmolive’s previous quarterly dividend of $0.52. This represents a $2.12 annualized dividend and a yield of 2.5%. The ex-dividend date is Monday, April 20th. Colgate-Palmolive’s dividend payout ratio (DPR) is currently 80.92%.

Insider Buying and Selling at Colgate-Palmolive

In other Colgate-Palmolive news, insider Sally Massey sold 15,851 shares of the company’s stock in a transaction on Thursday, February 5th. The shares were sold at an average price of $95.03, for a total transaction of $1,506,320.53. Following the completion of the sale, the insider owned 13,751 shares in the company, valued at approximately $1,306,757.53. The trade was a 53.55% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, insider John Hazlin sold 20,989 shares of the stock in a transaction on Tuesday, February 10th. The shares were sold at an average price of $94.25, for a total value of $1,978,213.25. Following the completion of the transaction, the insider directly owned 17,645 shares in the company, valued at approximately $1,663,041.25. This trade represents a 54.33% decrease in their position. The SEC filing for this sale provides additional information. Over the last ninety days, insiders have sold 184,683 shares of company stock valued at $17,486,693. 0.41% of the stock is currently owned by corporate insiders.

About Colgate-Palmolive

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.